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Adipose (Adp) is an evolutionarily conserved
gene isolated from naturally occurring obese
flies homozygous for an adp mutation. Here
we show that the anti-obesity function of Adp
(worm Y73E7A.9, fly adp, and murine Wdtc1)
is conserved from worms to mammals. Further,
Adp appears to inhibit fat formation in a dos-
age-sensitive manner. Adp heterozygous flies
and Adp heterozygous mutant mice are obese
and insulin resistant, as are mice that express a
dominant negative form of Adp in fat cells. Con-
versely, fat-restricted Adp transgenic mice are
lean and display improved metabolic profiles.
A transient transgenic increase in Adp activity
in adult fly fat tissues reduces fat accumulation,
indicating therapeutic potential. ADP may elicit
these anti-adipogenic functions by regulating
chromatin dynamics and gene transcription, as
it binds both histones and HDAC3 and inhibits
PPARg activity. Thus Adp appears to be in-
volved in an ancient pathway that regulates fat
accumulation.
INTRODUCTION
Fat-storing tissues play essential roles such as regulating
metabolism and lifespan (Bluher et al., 2003; Spiegelman
and Flier, 2001). Adipocyte dysfunction underlies obesity
and is central to the metabolic derangements in type II
diabetes (Must et al., 1999). The dramatic rise in obesity
and diabetes have led to a public health crisis that could
be addressed by identifying genes that influence adipo-
genesis and metabolism (Olshansky et al., 2005).
Studies of mammalian cell culture adipogenic models
have revealed a transcriptional hierarchy, including
C/EBPs, PPARg, and SREBP, that controls adipogenesis
(Rosen et al., 2000). PPARg, a nuclear hormone receptor
(NHR), is a central regulator of fat biology (Lehrke and La-
zar, 2005; Rosen et al., 2000). NHRs are ligand-regulated
transcription factors (Evans, 2005; Mangelsdorf et al.,Cell Meta1995). In the absence of ligand, NHRs repress transcrip-
tion by interacting with corepressor molecules (Lazar,
2003; Perissi et al., 2004). Corepressor complexes also
regulate non-NHR transcription factors (Rosenfeld et al.,
2006; Smith and O’Malley, 2004). Corepressors either
contain or recruit histone deacetylases (HDACs), or other
chromatin modifying enzymes, that render chromatin
structure unfavorable for transcription (Rosenfeld et al.,
2006; Smith and O’Malley, 2004). HDAC3 is an important
component of the repressive complex that regulates adi-
pogenic genes (Fajas et al., 2002; Fu et al., 2005). Compo-
nents of the corepressor complex also directly bind
histone 2B (H2B) and histone 4 (H4) (Lorain et al., 1998;
Magnaghi et al., 1998; Yoon et al., 2005). Gene expression
is induced upon exchange of the corepressor complex for
a coactivator complex, which often has histone acetyl-
transferase activity. Thereby chromatin is remodeled into
a form accessible for transcriptional activation (Rosenfeld
et al., 2006; Smith and O’Malley, 2004). The role of histone
modifications in controlling gene expression has been
conserved during eukaryotic evolution.
Invertebrate models such as C. elegans and D. mela-
nogaster are powerful systems for the discovery and anal-
ysis of genes critical to human health and disease. These
advantages have yet to be fully applied to fat biology in
part because of concerns that differences exist between
invertebrate and mammalian fat including the observa-
tions that worm and fly fat is not stored in dedicated
adipocytes but rather in moremultifunctional cells (Rosen,
2006). Molecular studies also highlight potential differ-
ences (Tong et al., 2000). Other data, however, support
the notion that invertebrates may provide useful informa-
tion on adipocyte biology (Ashrafi et al., 2003; Gronke
et al., 2005; McKay et al., 2003; Ruden et al., 2005).
Almost 50 years ago, Winifred Doane hypothesized that
climates marked by cycles of famine might select for or-
ganisms highly efficient at fat storage to allow for survival
during times of limited food. Dr. Doane successfully iso-
lated such an obese D. melanogaster mutant, which she
ultimately termed adipose (adp), from a laboratory strain
whose origin was Kaduna, Nigeria (Clark and Doane,
1983; Doane, 1960a, 1960b). Recently Doane and col-
leagues cloned the fly Adp gene, which encodes a novel
protein conserved as a single copy from flies to humansbolism 6, 195–207, September 2007 ª2007 Elsevier Inc. 195
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Adp is a conserved antiobesity gene(Hader et al., 2003). The fly adpmutation is a 23 base pair
deletion predicted to result in premature termination of
ADP. ADP contains multiple protein interaction domains
(6WD40, 3 tetratrico peptide repeat [TPR]) andmay there-
fore function as a nexus for a protein complex important
in fat biology (Blatch and Lassle, 1999; Hader et al., 2003;
Smith et al., 1999). AlthoughAdphas abroadpattern of ex-
pression, the primary phenotype observed in adp null flies
is increased triglyceride storage in the fat body, the fly
adipose organ (Hader et al., 2003).
In worms, we found that C.elegans Adp (Y73E7A.9)
RNAi increased fat accumulation. Adp heterozygous flies
also displayed metabolic phenotypes indicating dosage-
sensitivity in fat formation. Transgenic expression of Adp
in the fat body reduced fly fat formation even when in-
duced only briefly during adulthood. Murine Adp (Wdtc1)
also blocked fat fat formation in cell culture adipogenesis
systems. Next we generated mice with LacZ inserted into
the Adp locus. Adp/ mutant mice were born at well
below the expected Mendelian ratio, making analysis of
metabolic phenotypes difficult. However, Adp+/ mice,
like adp+/ flies, were obese and insulin resistant. Simi-
larly, transgenic mice that expressed a dominant negative
Adp in fat cells were obese and hyperglycemic. Con-
versely, transgenic mice that expressed wild-type Adp in
fat were lean and had improved metabolic parameters.
ADP appears to function in the nucleus where it interacts
with H2B, H4 and HDAC3, indicating that ADP may be
present in a chromatin remodeling complex. PPARg may
be a target of this complex as ADP inhibits PPARg tran-
scriptional activity. These data are consistent with the no-
tion thatAdp is a conserved dosage-sensitive anti-obesity
gene that functions in a corepressor complex to regulate
gene expression.
RESULTS
Inhibiting Adipose StimulatesWorm Fat Formation
We designed a genome-wide screen, coupling RNAi, light
microscopy and staining with Nile Red, a dye whose fluo-
rescent intensity reflects fat content, to identify genes
involved in C. elegans fat formation (McKay et al., 2003).
We observed that RNAi with a construct targeting the
50 region of the C. elegans Adp homolog (Figure 1A) pro-
duced worms with increased fat formation as evidenced
by enhanced opacity and increased Nile Red fluorescence
(Figure 1B). RNAi with a second construct that targets
an independent region of Adp also produced an obese
phenotype, indicating specificity (Figure 1B). These data
support the idea that Adp has an anti-obesity function in
C. elegans.
Adipose Has Dosage-Sensitive Roles
in Fly Fat Biology
Adipose (adp) homozygous mutant flies are obese and
starvation resistant, but the homozygous state also has
negative consequences (Doane, 1960a; Doane, 1960b).
For example, adp homozygous mutants have decreased196 Cell Metabolism 6, 195–207, September 2007 ª2007 Elseviemobility compared to adp heterozygotes (Figure 1C). Since
adp heterozygosity might also engender some beneficial
effects during famine while minimizing deleterious se-
quelae (Clark and Doane, 1983; Doane, 1960a; Doane,
1960b), we evaluated the fat biology of adp+/ flies and
found a phenotype intermediate between wild-type and
adp nulls. In a starvation survival assay, which often corre-
lates with fat content (Djawdan et al., 1998), survival was
adp/ > adp+/ > adp+/+ (Figure 1D), consistent with prior
observations (Doane, 1960b). Triglyceridequantitationalso
revealed the same trend (Figure 1E). These data indicate
that Adp has dose-dependent effects on fly fat storage.
Adipose Fat Body Transgenesis Blocks Larval
and Adult Fly Fat Storage
Expression of Adp in fat cells rescued adpmutant obesity
and reduced fat storage, indicating that its anti-obesity
functions are primarily mediated within the fat cell (Hader
et al., 2003). We further analyzed this notion by generating
transgenic flies that expressed Adp (UAS-Adp) in a fat-re-
stricted manner under the control of the Dcg-Gal4 driver,
expressed in late embryonic, larval, and adult fat (Suh
et al., 2006). We also introduced a Dcg-GFP fat body
GFP transgenic reporter to visualize the fat body in intact
animals. We found that fat body transgenic expression of
Adp inhibited fat formation based upon reduced opacity,
decreased Nile Red and GFP fluorescence, and de-
creased fat body size (Figures 1F and 1G).
We also examined whether Adp might regulate adult fat
biology. For this, we generated two independent fat body
RU486-inducible GAL4 strains (FBI-19, FBI-26) in an en-
hancer trap screen (Roman et al., 2001). Adult flies of
these two lines express a UAS-GFP reporter in the fat
body when provided RU486 (Figures 1H and 1I). RU486
does not appear to affect the fat biology of FBI flies based
upon gross examination, fat body morphology and triglyc-
eride quantitation (Figures 1H, 1J and 1K). We crossed
both FBI-GAL4 lines with UAS-Adp flies and randomized
adult progeny to 5 days of vehicle or RU486. Gross obser-
vations, whole mount Nile Red stains, triglyceride quanti-
tation and starvation survival assays indicated that
RU486-treatment reduced FBI-GAL4; UAS-Adp fat accu-
mulation as compared to those treated with vehicle (Fig-
ures 1L, 1M, 1N, and 1O). These results indicate that the
anti-obesity effects of Adp can operate in adult fat tissues.
Adipose Inhibits Murine Fat Formation
To begin to characterize mammalian Adp, we evaluated
its relative expression in a variety of mouse tissues using
qPCR.We found thatmurine Adp, like fly Adp (Hader et al.,
2003), is widely expressed (Figure 2A). Attempts to gener-
ate high titer specific antibodies against murine ADP have
been unsuccessful. 3T3-L1 cells are a murine cell culture
adipogenic model that can be induced to differentiate
from preadipocytes to fat-storing cells that express adipo-
cyte markers (Rosen and Spiegelman, 2000). Adp was ex-
pressed in 3T3-L1 cells (Figure 2B) with highest levels in
preadipocytes (Figure 2B), although in a few cases the
levels were similar. Adp expression was also enriched inr Inc.
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Adp is a conserved antiobesity geneFigure 1. Inhibiting Adipose Stimulates Worm and Fly Fat Formation
(A) Alignment of worm (ce), fly (dm), mouse (m) and human (h) ADP protein. WD40 domains: light blue rectangles, TPR domains: orange rectangles.
The percentages refer to comparison with hADP.
(B) Progeny of control or Adp RNAi worms were examined with bright field microscopy in which increased opacity indicates more fat storage. Fat
content was also assessed with Nile Red, a lipid-specific dye. Worms are at the same developmental stage.
(C) Mobility of male adp+/ (Het) and adp/ (Homo) flies was assessed in a negative geotaxis assay. Mobility is plotted as the inverse of time (sec-
onds) required for flies to crawl a fixed distance.
(D) Adp+/+ wild-type, adp+/ (Het), and adp/ (Homo) male adult flies (n > 100) were deprived of food and survival was plotted.
(E) Triglycerides were quantified fromwell-fed adult male adp+/+ wild-type, adp+/ (Het), and adp/ (Homo) flies (n = 10 per genotype, averages from
4 experiments plotted).
(F) Larvae expressing a fat body GFP reporter either alone (control) or with Adp fat body transgenesis were photographed under bright field (left) or
GFP fluorescence (right) microscopy.
(G) Fat body explants of larvae described in F were stained with Nile Red and photographed with bright field (left) or fluorescence (right) microscopy.
(H, I) Adult fat body inducible (FBI)-GAL4; UAS-GFPmale reporter flies were randomized to vehicle (VEH) or inducer (RU486) and then the whole fly (H)
or fat body explants (I) were photographed. Wings and legs were removed in H for imaging.
(J, K) Single transgenic FBI-19male adult flies were treated with either vehicle or RU486 and photographed with light microscopy (J) or subjected to
triglyceride quantitation and levels were normalized to vehicle-treated flies (K) (n = 10 per treatment, averages from 5 experiments plotted). Wings and
legs were removed in J for photography.
(L) Adult FBI-19-Adp male flies were treated with vehicle or RU486 and then photographed. Arrow indicates abdomen and the fat body, which ap-
pears smaller after RU486 treatment. Wings and legs were removed for imaging.
(M) Flies described in L were stained with Nile Red and whole mounts were photographed.
(N) Triglyceride quantification of male adult FBI-19-Adp and FBI-26-Adp flies treated with vehicle or RU486. Values were normalized to vehicle or
RU486-treated single transgenic controls (n = 10 per treatment, averages from 5 experiments plotted).
(O) Day 7 starvation survival of male adult FBI-19-Adp and FBI-26-Adp flies treated with vehicle or RU486 (n > 50).
Similar results obtained for females in analyses performed in C-E and H-O. *p < 0.05; **p < 0.01; N/S not significant by t test. Error bars indicate stan-
dard error of the mean (SEM).Cell Metabolism 6, 195–207, September 2007 ª2007 Elsevier Inc. 197
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Adp is a conserved antiobesity geneFigure 2. Adp Inhibits Murine Adipogenesis
(A) qPCR analysis of Adp expression levels in various tissues from 4-month old ICR mice. Brown adipose tissue (BAT), inguinal white adipose tissue
(IWAT), perigonadal white adipose tissue (GWAT), mesenteric white adipose tissue (MWAT).
(B) 3T3-L1 cells were induced to form adipocytes and Adp levels were assessed with qPCR.
(C) Adp expression was quantified with qPCR in stromal-vascular (SV) and adipocyte (Adipo) fractions.
(D) Adp expression levels in adipose depots of littermates provided a normal or high fat diet (HFD) (left panel), genetically obese (ob/ob) fat depots
compared to littermate controls (middle panel), or mice subjected to a 24 hr fast compared to fed controls (right panel).
(E) Adp levels in 3T3-L1 cells infected with virus encoding GFP or Adp.
(F–H) 3T3-L1 cells were infected with virus encoding GFP or Adp, adipogenically induced, and adipogenesis was evaluated with (F) Oil Red O staining
(fat stains red), (G) triglyceride quantitation and (H) qPCR quantitation of the indicated markers. PPARg and C/EBPa are adipogenic transcription fac-
tors; aP2 marks differentiated adipocytes; adipsin and leptin are adipokines expressed by mature adipocytes; Pref-1 is a preadipocyte marker.
(I) NIH 3T3 cells were infected with virus encoding GFP or Adp, adipogenically induced, and adipogenesis evaluated with Oil Red O staining.
(J, K) MC3T3-E1 preosteoblastic cells were infected with GFP or Adp, osteogenically induced, and bone formation was assessed with (J) Von Kossa
staining (bone stains black) or (K) qPCR of osteogenic markers. Runx2 (Runx) and Osterix (Osx) are osteogenic transcription factors, and alkaline
phosphatase (Alp) and osteocalcin (OC) are bone differentiation markers.
*p < 0.05, **p < 0.01; N/S not significant by t test. Error bars represent SEM b-actin serves as a loading control.the stromal-vascular fraction of murine adipose depots,
thought to contain preadipocytes (Figure 2C) (Poznanski
et al., 1973; Soukas et al., 2001). We also evaluated Adp
expression in murine fat depots in response to genetic
and diet-induced obesity or fasting. We found that Adp
levels decreased in both forms of obesity and increased
upon fasting (Figure 2D), suggesting that Adp may regu-
late mammalian fat biology.198 Cell Metabolism 6, 195–207, September 2007 ª2007 ElseTo investigate a potential role for Adp inmammalian adi-
pogenesis, we first cloned murine Adp from a 3T3-L1
cDNA library. We then infected 3T3-L1 s with virus encod-
ing either GFP or murine Adp, which significantly in-
creased Adp expression (Figure 2E). When adipogenically
induced, the GFP cells became lipid-laden adipocytes
as evidenced by fat-specific stains and triglyceride quan-
titation (Figures 2F and 2G). In contrast, the Adp cellsvier Inc.
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Adp is a conserved antiobesity generetained preadipocyte morphology and accumulated only
trivial amounts of lipid (Figures 2F and 2G). Further, Adp
inhibited the expression of a panel of adipogenic markers
(Figure 2H). Expression of Pref-1, whose levels inversely
correlate with adipogenesis, increased (Figure 2H). Adp
also inhibited NIH 3T3 adipogenesis (Figure 2I). To test
specificity, we examined the effect of Adp on MC3T3-E1
cell culture osteogenesis. However, based upon Von
Kossa stain and molecular analyses, Adp did not alter
osteogenesis (Figures 2J and 2K).
To determine whether Adp could inhibit murine fat for-
mation, we placed it under the control of the 5.4kb aP2
promoter/enhancer (Figure 3A), which drives expression
in murine adipocytes, although it can be expressed in
some macrophages (Makowski et al., 2001; Ross et al.,
1990). We generated several independent lines of aP2-
Adp transgenics which had the same phenotype. qPCR
analyses showed that aP2-Adp mice expressed higher
levels of Adp in fat (Figure 3B). We first studied mice after
backcrossing into an ICR background. By 16 weeks the
weight of the aP2-Adp mice began to diverge from their
wild-type littermates and this was reflected in their ap-
pearance (Figures 3C and 3D). At 24 weeks, NMR and
fat depot analyses showed that the Adp transgenics had
significantly less body fat than controls (Figures 3E, 3F,
and 3G). The weights of other organs were unaffected
(Figure 3G). Histological analyses revealed that aP2-Adp
mice had significantly smaller adipocytes than controls
(Figure 3H). Plasma analyses showed reduced levels of
leptin and insulin in the aP2-Adp mice (Figure 3I). Glucose
tolerance tests (GTT) showed that the aP2-Adp mice had
significantly lower blood glucose levels than controls
(Figure 3J). Plasma triglyceride levels, food consumption,
body temperature, and activity were unchanged (Figures
3I and 3K, Supplemental Figure S1). aP2-Adp transgene-
sis also produced a lean phenotype on a pure B6 back-
ground (not shown).
Inhibiting Adipose Stimulates Murine
Fat Formation
To assess necessity, we used NIH 3T3 cells, which are
less adipogenic than 3T3-L1 s, and generated stable cells
that expressed control or Adp RNAi. Adp RNAi reduced
Adp transcript levels and increased adipogenesis as as-
sessed by Oil Red O stains, triglyceride quantitation, and
molecular analyses (Figures 4A, 4B, 4C, and 4D). A sec-
ond independent Adp RNAi construct produced equiva-
lent results (not shown).
To investigate structure-function relationships, we di-
vided murine Adp into several pieces designed around
the protein interaction domains and assayed their adipo-
genic activity (Figure 4E). We found that expressing the
carboxyl-portion of Adp (AdpC1) stimulated fat formation
(Figures 4E and 4F), mimicking the Adp RNAi phenotype.
AdpC1 seemed to function as a dominant negative form
of Adp based upon the observations that increasing
amounts of AdpC1 overcame the Adp effect while wild-
type Adp rescued the AdpC1 effect in a dose-dependent
fashion (Figures 4G and 4H).Cell MeSince AdpC1 appeared to act as a functional antagonist
of Adp, it provided a potential tool to dissect Adp function
in vivo. For this, we generated several aP2-AdpC1 trans-
genic and non-transgenic B6:D2F founders (Figure 5A).
Although aP2-AdpC1 transgenic mice had similar weights
as the control founders, NMR analysis showed that the
aP2-AdpC1 mice had increased fat content (Figures 5B
and 5C). Further, the transgenic WAT depots weighed
more than controls whereas non-adipose organs showed
no differences (Figure 5D). Histological studies showed
that the aP2-AdpC1 adipocytes were larger than control
adipocytes (Figure 5E). Food intake and body temperature
were not significantly altered (Figure 5F and Supplemental
Figure S2). In GTTs, the aP2-AdpC1 had higher blood
glucose levels (Figure 5G).
Adipose Heterozygous Mice Are Obese
Next we generated mice with a splice acceptor-LacZ-Neo
resistance cassette inserted into the Adp locus at a posi-
tion that should produce an early truncation of the ADP
protein at amino acid 15 (Figure 6A). Expression levels of
Adp in adipose tissues, based upon qPCR analyses,
were reduced by more than half in the Adp heterozygotes
(Supplemental Figure S3). We bred the Adp mutation 7 or
8 generations (F7, F8) into the ICR background and then
intercrossed F7 or F8 ICR Adp heterozygotes. However,
Adp homozygotes were born at markedly reduced ratios
compared to Mendelian predictions (Figure 6B). Although
some Adp homozygotes were obese, their scarcity pre-
cluded statistically significant analyses and adult pheno-
types observed in the few mice that escaped embryonic
lethality may reflect secondary rather than primary effects.
Since adp heterozygous flies were obese, we examined
F7 or F8 ICR Adp heterozygotes. We found that male and
female Adp heterozygous mice were obese compared to
wild-type littermates based upon weight, appearance,
NMR fat quantitation, and assessment of explanted fat
depots (Figures 6C, 6D, 6E, 6F, and 6G). Other organs,
such as the heart or spleen, had similar weights (Fig-
ure 6G). Histology showed that the Adp heterozygotes
had enlarged adipocytes (Figure 6H). Plasma leptin and
insulin levels were significantly elevated in Adp heterozy-
gotes; triglyceride levels were unchanged (Figure 6I). In
GTTs, the Adp heterozygotes had a trend toward hyper-
glycemia, which often did not reach statistical significance
(Figure 6J). Thus, Adipose heterozygosity in flies and mice
produces an obese phenotype, supporting the notion
that Adp is a conserved dosage-sensitive regulator of
adipocyte biology.
Adipose Functions in the Nucleus
We explored ADP subcellular distribution by incorporating
an N-terminal GFP-tag (Figure 7A). We first confirmed that
GFP-Adp remained functional in inhibiting 3T3-L1 adipo-
genesis (Figure 7B). Then we expressed GFP-Adp and
examined subcellular distribution with 5 mm Z-series con-
focal microscopy. In low, medium, and high expressing
cells, GFP-Adp was located in both the cytosol and nu-
cleus with higher levels in the cytosol (Figure 7C). Wetabolism 6, 195–207, September 2007 ª2007 Elsevier Inc. 199
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Adp is a conserved antiobesity geneFigure 3. Fat-Selective Adp Transgenic
Mice Are Lean and Insulin Sensitive
(A) aP2-Adp transgene.
(B) qPCR analysis of Adp expression in fat
pads removed from control and aP2-Adp
transgenic littermates.
(C) Weight curves of aP2-Adp transgenic mice
and littermate controls (n = 8).
(D) Photograph of a representative control (top)
and aP2-Adp transgenic mouse (bottom).
(E) NMR analyses of fat content of aP2-Adp
transgenic mice and littermate controls (n = 8).
(F) Photograph of representative perigonadal
white adipose tissue (WAT) from control and
aP2-Adp transgenics.
(G) Average weights of inguinal (I), mesenteric
(M), and perigonadal (G) WAT depots and the
indicated organs from aP2-Adp transgenics
and littermates. (n = 8).
(H) Histological sections of inguinal (Ing) and
perigonadal (Gon) WAT depots of control and
aP2-Adp transgenic mice.
(I) Analyses of average leptin, insulin, and tri-
glyceride levels in plasma taken from aP2-
Adp transgenic mice and littermates (n = 8).
(J) GTTs of aP2-Adp transgenics mice and
control littermates.
(K) Food consumption wasmeasured and plot-
ted as the average of the indicated littermate
control and aP2-Adp transgenic cohorts (n =
8). D-K studies performed at 6 months of age.
*p < 0.05, **p < 0.01, ***p < 0.005; N/S not sig-
nificant by t test. Error bars indicate SEM.also GFP tagged the dominant negative AdpC1 domain
(Figure 7D); GFP-AdpC1 stimulated adipogenesis like un-
tagged AdpC1 (Figure 7E). Z-series confocal microscopy200 Cell Metabolism 6, 195–207, September 2007 ª2007 Elsevishowed that GFP-AdpC1 was also expressed in both
the cytosol and nucleus with nuclear levels greater than
cytosolic levels (Figure 7F).er Inc.
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Adp is a conserved antiobesity geneFigure 4. Inhibiting Adp StimulatesMammalian Adipogenesis
(A–D) NIH 3T3 s stably expressing either control RNAi or Adp RNAi
were evaluated with (A) Adp qPCR (B) Oil Red O staining, (C) triglycer-
ide quantitation, and (D) qPCR molecular analyses as in Figure 3.
(E) Cartoon showing Adp structure, the series of deletion mutants, and
their effects on adipogenesis. FL = full-length. Red arrows indicate
effect on adipogenesis. WD40 domains: light blue rectangles, TPR
domains: orange rectangles.
(F) NIH 3T3 cells expressing either GFP or AdpC1were stained with Oil
Red O to assess fat storage.Cell MetabTo identify the compartment in which ADP elicits its anti-
adipogenic actions, we targeted ADPeither to the nucleus,
with a nuclear localization signal fusion (NLS-Adp), or away
from the nucleus, with a nuclear export sequence fusion
(NES-Adp) (Figures 7G and 7I). NLS-Adp blocked adipo-
genesis while NES-Adp did not and in some conditions
even stimulated adipogenesis, like a dominant negative
Adp (Figures 7Hand7J). Thus it is likely the nuclear fraction
of ADP functions to inhibit adipogenesis.
Adipose Binds Histones and HDAC3
We performed a yeast two-hybrid screen with full-length
murine Adp and a mouse library, and we isolated multiple
independent clones of histone 2B (H2B). We tested
whether this interaction occurred in mammalian cells and
also tested histone 4 (H4), since other WD40 proteins in-
teract with this pair of histones (Li et al., 2000; Magnaghi
et al., 1998; Yoon et al., 2005). We found that FLAG-ADP
co-immunoprecipitated with either myc-H2B or myc-H4
(Figure 7K). Several proteins that interact with H2B and
H4 function in transcriptional corepressor complexes
that contain HDAC3, a regulator of adipocyte biology
(Fajas et al., 2002; Fu et al., 2005; Guenther et al., 2000;
Li et al., 2000; Yoon et al., 2003; Yoon et al., 2005). We
therefore examined whether ADP interacts with HDAC3,
and found that these two molecules co-purify. (Figure 7L).
These data indicate that H2B, H4 and HDAC3may exist in
complexes that contain ADP and raise the possibility that
Adp functions as a transcriptional corepressor.
Next, we attempted to address the functional relevance
of ADP and HDAC3 interactions. For this, we infected 3T3-
L1 s with GFP or Adp virus, adipogenically induced and
treated thecellswith vehicle or theHDAC inhibitors sodium
butyrate and 4-phenyl butyrate, which are limited as they
inhibit multiple HDAC family members (Jung, 2001). The
HDAC inhibitors significantly reversed the Adp-dependent
blockadeof adipogenesis (Figures 7Mand7N), suggesting
that Adp functions upstream of histone deacetylation
during adipogenesis.
If ADPdoes function in a corepressor complex, itmay in-
hibit key adipogenic transcription factors such as C/EBPs,
PPARg, and SREBP. To investigate this possibility, we as-
sessed the effect ofADPonC/EBP-, PPARg-, andSREBP-
dependent transcriptional reporters. We found that ADP
inhibited the action of PPARg, but not the other factors
(Figure 7O, Supplemental Figure S4). Conversely, Adp
RNAi significantly stimulated PPARg reporter expression
(Figure 7P). These results were consistent with the prior
observations that PPARg target gene expression was al-
tered by Adp levels in cell culture adipogenesis (Figures
(G) GFP (–), Adp, and increasing amounts of AdpC1 were introduced
into 3T3-L1 s and fat accumulation evaluated with Oil Red O (top)
and triglyceride quantitation (bottom). Purple shows increasing
concentration of AdpC1 while Adp (green) is kept constant.
(H) Schema as in G, except in this case AdpC1was held constant while
Adp levels were varied.
**p < 0.01; N/S not significant by t test. Error bars represent SEM.olism 6, 195–207, September 2007 ª2007 Elsevier Inc. 201
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Adp is a conserved antiobesity geneFigure 5. Fat-Selective Blockade of
Adipose Produces Murine Obesity and
Hyperglycemia
(A) aP2-AdpC1 construct.
(B, C) Average weights (B) and average NMR
fat content (C) of aP2-AdpC1 transgenic and
non-transgenic founders (n = 10).
(D) Average weights of inguinal (I), mesenteric
(M), and perigonadal (G) WAT depots as well
as the indicated organs from aP2-AdpC1 trans-
genic mice and littermate controls (n = 10).
(E) Histological analyses of control and aP2-
AdpC1 inguinal (Ing, top) and perigonadal
(Gon, bottom) WAT.
(F) Food intake of aP2-AdpC1 transgenic mice
and littermates.
(G) GTTs of aP2-AdpC1 mice and control litter-
mates. Analyses in panels B-G on 8-month old
mice.
*p < 0.05, **p < 0.01; N/S not significant by
t test. Error bars represent SEM.2H and 4D). Next, we examined PPARg target gene ex-
pression in fat depots of the Adp heterozygous and the
aP2-Adp transgenic mouse models. The levels of expres-
sion of all PPARg targets were increased in Adp heterozy-
gous fat and reduced in aP2-Adp transgenic fat, which
may result from a direct effect on PPARg action or a sec-
ondary response to altered fat accumulation (Figure 7Q
and 7R).
DISCUSSION
The search to identify molecules that underlie fat accumu-
lation and glucose homeostasis has taken on additional
urgency due to the recent dramatic increase in obesity
and diabetes (Campbell and Dhand, 2000; Must et al.,
1999). Mammalian adipocytes store large amounts of lipid202 Cell Metabolism 6, 195–207, September 2007 ª2007 Elseand secrete a variety of hormones that regulate feeding
behavior and metabolism (Friedman and Halaas, 1998).
The ability to store fat was acquired early in evolution
and is essential for survival of multi-cellular animals. Adp
encodes an evolutionarily conserved protein that displays
functional conservation between invertebrate and mam-
malian systems. Loss of Adp function leads to increased
fat accumulation in worms, flies, mammalian tissue cul-
ture, and mice. Conversely, increasing Adp activity blocks
fat formation in flies, mammalian cell culture and mice. In
the fly model, a brief induction of Adp activity in adult fat
tissues reduced fat accumulation. If this phenotypic re-
sponse is conserved to mammals, the Adp pathway could
be a rational target for obesity and diabetes therapies.
The conservation of Adp function appears to extend
to dosage-sensitive phenotypes. Adp heterozygous fliesvier Inc.
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Adp is a conserved antiobesity geneFigure 6. Adp Heterozygous Mutant
Mice Are Obese and Insulin Resistant
(A) Schema of the wild-type (WT) Adp locus
and the mutant (Mut) Adp allele. Splice Ac-
ceptor (SA) and the lacZ-neomycin (b-geo)
cassette were inserted and disrupt gene
expression from the second exon (E2). The
location of the genotyping primers (F1, R1,
R2) are illustrated.
(B) Genomic DNA was extracted from pups of
multiple Adp+/ by Adp+/ intercrosses and
genotyped for the presence of Adp mutant
and wild-type alleles.
(C) Average weights of littermate matched
female (control n = 10 mice, Adp Het n = 12)
and male (control n = 15, Adp, Het n = 20)
cohorts.
(D) Photograph of representative wild-type
(Cont) and Adp+/ mice (Het).
(E) Average fat content as assessed by NMR of
littermate matched female (control n = 10mice,
Adp Het n = 12) and male (control n = 15, Adp
Het n = 20) cohorts.
(F) Photograph of representative perigonadal
white adipose tissue (WAT) explants from sib-
ling wild-type (Cont) and Adp+/ (Het).
(G) Average weights of inguinal (I) and perigo-
nadal (G) WAT and indicated organs of wild-
type and Adp heterozygous littermates.
(H) Histological analyses of inguinal (Ing) and
perigonadal (Gon) WAT.
(I) Plasma of control and Adp heterozygous
cohorts was analyzed for leptin, insulin and
triglyceride levels.
(J) GTTs of Adp heterozygous and control sib-
lings (n = 8). Analyses in panels C-J done on
4-month old mice.
*p < 0.05, **p < 0.01, ***p < 0.005 by t test. N/S
not significant. Error bars indicate SEM.have intermediate levels of fat accumulation between
wild-type and homozygous mutants, and Adp heterozy-
gousmice are also obese. Such autosomal dominant phe-
notypes caused by loss-of-functionmutations are uncom-
mon and can occur in genes that are key regulators of the
process under study, such as the rate limiting enzyme in
a metabolic pathway (Wilkie, 1994). Other WD40 repeat
proteins also display haploinsufficient phenotypes (Hirot-
sune et al., 1998; Li and Roberts, 2001; Sidow et al.,
1999; Zhang et al., 2004). This feature of WD40 proteins
is thought to stem from their role as organizing centers
of protein complexes.Cell MetAdp null flies were isolated as a naturally occurring
obese variant. However, nullizygosity at the D. mela-
nogaster adp locus engenders negative consequences
(Figure 1C) (Doane, 1960a; Ruden et al., 2005). The dele-
terious effects of Adp loss are also observed in mammals,
as the majority of the Adp homozygous mutant mice that
we attempted to generate for this study died in utero.
We have yet to ascertain the cause of the embryonic le-
thality, which could result from non-adipose functions as
Adp is widely expressed. Since Adp has high levels of
expression in the brain and testis these tissues could
plausibly be affected and deserve significant scrutiny.abolism 6, 195–207, September 2007 ª2007 Elsevier Inc. 203
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Adp is a conserved antiobesity geneFigure 7. ADP Functions in the Nucleus and Interacts with a Corepressor Complex
(A) GFP-Adp chimera. WD40 domains: light blue rectangles, TPR domains: orange rectangles, GFP: green rectangle.
(B) 3T3-L1 s were infected with virus containing either GFP or GFP-Adp, adipogenically induced and Oil Red O stained.
(C) GFP-Adp was introduced into cells and its localization was assessed with confocal microscopy. White arrow indicates nucleus.
(D) GFP-AdpC1 chimera.
(E) NIH 3T3 s were infected with GFP or GFP-AdpC1 and adipogenesis was assessed with Oil Red O staining.
(F) Confocal microscopic photograph of GFP-AdpC1 expressing cells. White arrow designates nucleus.
(G) Nuclear localization signal (NLS)-Adp chimera. NLS: yellow rectangle.
(H) 3T3-L1 s were infected with virus encoding GFP or NLS-Adp, adipogenically induced, and stained with Oil Red O.
(I) Nuclear export signal (NES)-Adp chimera. NES: aqua rectangle.
(J) 3T3-L1 s were infected with GFP or NES-Adp virus, cultured in media supplemented with insulin, and then stained with Oil Red O.
(K) HEK293 s were transfected with a FLAG vector, a myc vector, FLAG-Adp, myc-H2B, or myc-H4 as indicated. After the cells were lysed, part of the
homogenates was removed (input) and the remainder immunoprecipitated (IP) with anti-myc antibody. The resultant immunoprecipitates were sub-
jected toWestern blots (WB) against the FLAG tag (top panel) or themyc tag (bottom panel). 10%of the homogenate was also evaluatedwithWestern
blots using the indicated antibodies.204 Cell Metabolism 6, 195–207, September 2007 ª2007 Elsevier Inc.
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Adp is a conserved antiobesity geneWorms, flies,mice and humans all contain only one copy
of Adp. ADP contains 9 protein interaction domains (6
WD40, 3 TPR) and no predicted catalytic domains. Al-
though WD40 proteins have other functions, a common
theme is that they act as transcriptional corepressors
through interactions with (and connections to) transcrip-
tion factors, histones, and histone-modifying enzymes
(Cerna and Wilson, 2005; Chen and Courey, 2000; Perissi
et al., 2004; Yoon et al., 2005). ADP associates with H2B,
H4, and HDAC3 raising the possibility that ADP functions
in a transcriptional corepressor complex (Guenther et al.,
2000; Li et al., 2000; Lorain et al., 1998; Magnaghi et al.,
1998; Yoon et al., 2003). HDAC3 corepressor complexes
are important in mammalian adipogenesis (Fajas et al.,
2002;Fuet al., 2005).PPARghasbeen identifiedasa target
of the HDAC3 corepressor and we find that Adp levels can
influence PPARg activity in various contexts. The ability of
ADP to regulate PPARg function may account for at least
part of Adp’s anti-adipogenic role and supports the notion
that Adp may act in a therapeutically relevant pathway.
Although the mechanism by which Adp reduces mam-
malian fat storage might involve inhibiting PPARg, no
PPARg ortholog has yet been identified in flies. So despite
the conservation of primary structure and biological func-
tion, it is possible that part of Adp’s fat inhibitory mecha-
nisms evolved in concert with the formation of dedicated
adipocytes present in higher organisms. Since flies and
other invertebrates contain fat but no clear PPARg homo-
log, it is likely that Adp functions in amoreprimordial protein
complex, for example the corepressor complex, that func-
tioned to restrain fat accumulation before PPARg existed.
Invertebrates and vertebrates store fat, which in turn
controls many diverse aspects of the life cycle. However,
a burgeoning epidemic of obesity and diabetes affects
millions and is altering our health care system. Therefore,
elucidating the molecules that underlie fat accumulation
and glucose homeostasis is an important task. The accu-
mulated data suggest that Adp restrains invertebrate and
vertebrate fat storage and does so in a dosage-sensitive
manner. The functional conservation fromworms tomam-




Two non-overlapping RNAi constructs targeting C. elegans Adp were
generated by PCR amplification of cDNA isolated from wild-type (N2)Cell Meworms. RNAi and Nile Red stains were as described (McKay et al.,
2003).
Fly Stocks
The adp60 mutant was a gift of Dr. Doane (Clark and Doane, 1983).
Newly eclosed flies reared under identical conditions were cultured
for a week with abundant yeast paste before analysis. UAS-Adp
stocks were a gift of Dr. Kuhnlein (Hader et al., 2003) and the Dcg-
GAL4 fat body driver was described previously (Suh et al., 2006).
Dcg-GFP fat body reporter flies were generated by P-element medi-
ated transformation of a plasmid with 10 kb upstream of the ATG
of the Drosophila collagen gene (Dcg) fused to GFP. FBI-GAL4 lines
were generated by mobilizing the p[Switch] element (gift of Dr. Davis)
and screening for lines with specific GFP expression in the fat body
after feeding 200 mM RU486 (Sigma) (Roman et al., 2001). FBI-GAL4
drivers were crossed to either UAS-GFP or UAS-Adp and the resulting
5-day old adult progeny, or the salient controls, were fed yeast con-
taining vehicle (1.6% ethanol) or 200 mM RU486 for 5 days.
Fly Starvation and Triglyceride Assays
Adult flies emerging from uncrowded cultures on the same day were
collected and cultured for another week under well-fed conditions.
Food was removed from cultures of 100 flies of each sex while
providing unlimited water and death was scored daily. Triglyceride
quantitation was performed as described (Suh et al., 2006).
Fat Body Visualization and Nile Red Staining
Larvae or adult flies were briefly immersed in methanol prior to micro-
scopic analysis or dissection. For Nile Red, whole flies or dissected fat
bodies were fixed in formalin, permeabilized in 0.2% Triton X-100
solution and stained with Nile Red.
Retrovirus Production and Infection
Standard methods (Suh et al., 2006) were used to generate recombi-
nant retroviruses and to virally transduce 3T3-L1, NIH 3T3 and
MC3T3-E1 cells.
Cell Culture, Adipogenic and Osteogenic Differentiation
Mouse NIH 3T3 fibroblasts, 3T3-L1 preadipocytes, MC3T3-E1 preos-
teoblast cells, and C3H10T1/2 cells were purchased from ATCC and
maintained in DMEM or a-MEM [for MC3T3-E1] with 10% calf serum.
3T3-L1 and NIH 3T3 cells were induced to undergo adipogenesis as
described (McKay et al., 2003; Suh et al., 2006). NIH 3T3 cells were
cultured on gelatin coated plates, induced for 6 days in insulin, dexa-
methasone, and IBMX, and then documented after 2 weeks of culture
in 10% FBS and insulin. MC3T3-E1 cells were osteogenically differen-
tiated as described (Wang et al., 1999). Sodium butyrate and 4-phenyl
butyrate (Calbiochem) were resuspended in sterile water.
RNA Extraction, CDNA Synthesis, and qPCR
Total RNA frommouse tissues or cultured cells was extracted with Tri-
zol (Invitrogen), RNase-free DNase I-treated, and reverse-transcribed
using random hexamers and M-MLV-reverse transcriptase (Invitro-
gen). Gene expression was measured through real-time PCR analysis(L) HEK293s were transfected with a FLAG vector, a myc vector, FLAG-HDAC3, or myc-Adp. The cells were lysed, part of the homogenates was
removed and the remainder divided and immunoprecipitated with antibodies directed against either the myc or FLAG epitopes. The resultant immu-
noprecipitates were subjected to Western blots against the other tag (top two panels). The homogenates were also directly evaluated with Western
blots as indicated. Bottom panel is the myc immunoprecipitates Western blotted with myc antisera.
(M) 3T3-L1 s expressing either GFP or Adp were adipogenically induced in the presence of vehicle (VEH) or 1.5 mM of HDAC inhibitors sodium bu-
tyrate (NaB) or 4-phenylbutyrate (4-PB), and then stained with Oil Red O.
(N) The Oil Red O stain of cells in M was extracted and quantified by measuring absorbance (620nm).
(O) PPARg luciferase assay: GFP or Adp along with PPARg, a PPRE-luc reporter, and a renilla luciferase control were transfected into the indicated
cell lines and luciferase activity was measured and then standardized with renilla. These normalized values were plotted as PPARg activity.
(P) The indicated cell lines, expressing control RNAi or Adp RNAi together with PPARg, PPRE-luc, and renilla, were assayed for luciferase activity as in O.
(Q,R)qPCRanalysesofPPARg targetgeneexpression ingonadal fatof (Q)control andAdpheterozygousmiceor (R)control andaP2-Adp transgenicmice.
FAS fatty acid synthase, LPL lipoprotein lipase, **p < 0.01.tabolism 6, 195–207, September 2007 ª2007 Elsevier Inc. 205
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Adp is a conserved antiobesity geneusing SYBR Green Master Mix reagent (Applied Biosystems, 7500
Real-Time PCR System). Real-time PCR values for gene expression
were normalized over endogenous b-actin expression. Real-time
primer sequences are available upon request.
Analysis of Cell Culture Lipid Accumulation
Lipid droplets were stained with Oil Red O; Oil Red O content was
measured spectrophotometrically as previously described (McKay
et al., 2003; Suh et al., 2006). To quantify triglyceride levels, cells
were lysed in 0.5% SDS/PBS and triglyceride content was measured
using the Infinity Triglyceride Reagent (ThermoElectron). Protein con-
centrations used to normalize triglyceride content were measured
with a BCA protein assay (Pierce).
Cell Culture RNAi
The indicated cell lines were transfected with either control mU6neo
shRNA plasmid or mU6neo-Adp shRNA plasmids that contain the ap-
propriate hairpins to reduce the expression of murine Adp. Stable
clones were selected in 400 mg/ml G418 for one week and then the
remaining G418-resistant stable clones were pooled together for
further experiments. shRNA mediated knockdown of the targeted
message was determined by qPCR.
Transgenic Mice
aP2-Adp and aP2-AdpC1 transgenic constructs were generated by
cloning mouse Adp or the AdpC1 fragment downstream of the
5.4 kb aP2 enhancer (gift of Dr. Spiegelman). Transgenic founders
were further bred to establish lines (aP2-Adp), backcrossed two
generations into ICR, and then intercrossed or used directly (aP2-
AdpC1) for the studies.
Adp Mutant Mice
Adp mutant gene trap ES cell line RRF015, containing an insertion
between the 1st and 2nd coding exons, was purchased from Bay-
Genomics. We confirmed the insertion site and injected the Adp
mutant ES cells into C57BL/6J blastocysts to produce chimeric
mice. The chimeras were bred to ICR strains and heterozygous mice
were backcrossed into ICR for > 6 generations.
Mouse Studies
Mice were housed in a 12:12 light:dark cycle. Chow (Teklad) and water
were provided ad libitum unless otherwise noted. Body weight was re-
cordedweekly. Total body fat mass of overnight fastedmice wasmea-
sured by NMR spectroscopy on the Minispec mq spectrometer
(Bruker). Food intake and core body temperature were recorded daily
for 5 consecutive days in the week prior to sacrifice. Mouse tissues
were harvested and weighed before freezing at80C for RNA extrac-
tion or fixed in formalin for paraffin embedding. For histology, 8 mm
sections were stained with hematoxylin and eosin. Ob mutant and
C57BL/6J mice were purchased from Jackson Laboratories. For
GTTs, overnight fasted mice received a 1.5 g glucose/kg body weight
intraperitoneal injection of 75 mg/ml glucose-PBS solution. Tail blood
was drawn at the indicated intervals and blood glucose levels were
measured with a TrueTrack glucometer. For diet-induced obesity
(DIO), we randomized 5-week old inbredC57BL/6J littermates to either
normal (4% fat, Teklad) or high fat (60% fat, Research Diets) chow. Af-
ter four months, the identical fat depots were explanted from all mice in
both cohorts and RNA was extracted and analyzed for gene expres-
sion with qPCR as described above. For genetic obesity, ob/ob mice
and control littermates were provided normal chow (4% fat, Teklad)
and at six months of age fat pad gene expression was analyzed as de-
scribed. Fat depot gene expression was also analyzed in 5-month old
inbred C57BL/6J littermates randomized to either ad libitum food or to
a 24 hr fast with water provided. Veterinary care was provided by the
Division of Comparative Medicine. All animals were maintained under
the guidelines of the U.T. Southwestern Medical Center Animal Care
and Use Committee according to NIH guidelines.206 Cell Metabolism 6, 195–207, September 2007 ª2007 ElsevYeast Two Hybrid
The yeast two hybrid screen was done as we described (Peters et al.,
1999). Full-length murine Adp was cloned into the pGBKT7 bait vector
(BD Biosciences) and transformed into L40 yeast. 1 X 105 clones of
a mouse library (pGAD) were screened and several in-frame, indepen-
dent isolates of H2B were obtained.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and four figures and can be found with this article online at http://
www.cellmetabolism.org/cgi/content/full/6/3/195/DC1/.
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